ARU-24411-27541
5 vaccinations
22 coded responses
38 check-ins
20 free-text entries
6 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 494 / MI
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-16
Dose 1 — Pfizer-BioNTech
-
2021-03-17
Registered in v-safe
-
2021-03-17
Dose 2 — Pfizer-BioNTech
-
2021-03-17
Survey response — day 0, dose 2MedDRA: Joint stiffness — Feeling: Fair · Fever · Chills, Joint pains · Be unable to do your normal daily activitiesFree text: Stiff jawMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-18
Survey response — days 1–6 daily, dose 2MedDRA: Joint stiffness, Lymphadenopathy, Musculoskeletal stiffness — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesFree text: Stiff jaw and neck, swollen lymph node, all left sideMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Survey response — days 1–6 daily, dose 2MedDRA: Joint stiffness — Feeling: Good · Fatigue or tirednessFree text: No jaw stiffness, No swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-21
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy, Oropharyngeal pain — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Sore throat and swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy, Oropharyngeal pain — Feeling: Fair · Fever · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Swollen lymph nodes, sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-23
-
2021-03-24
Health check-in — day 7, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-04-28
-
2021-06-16
Survey response — 3 months, dose 2MedDRA: Conjunctivitis, Eye irritation, Fatigue, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Eye irritations just recently re-diagnosed as Pink Eye and some fatigue. · Healthcare visit (other): Outpatient Eye ClinicMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-16
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-06-28
-
2021-09-15
Survey response — 6 months, dose 2MedDRA: Dermatitis contact, Eye disorder, Inflammation, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: I am having ongoing problems with my eyes..requiring steroid drops and have had the worst case of poison Ivy Ive ever had requiring 2 courses of prednisone. ALL issues related to some kind of inflammation and NOT typical for me :/ · Healthcare visit (other): Ophthalmology appointmentsMedDRA releases: 2024-11 · check-in free text available
-
2021-09-15
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-09-16
Call successfulCompleted over the phone
-
2021-10-08
Dose 3 — Pfizer-BioNTech
-
2022-03-17
Survey response — 12 months, dose 2MedDRA: Eye disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: I have had ongoing problems with my eyes, requiring prescription eye drops..but otherwise I have been great.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-17
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-03-19
Call successfulDoes not wish to fill out VAERS report
-
2022-05-04
Dose 4 — Pfizer-BioNTech
-
2022-05-06
Survey response — days 1–6 daily, dose 4MedDRA: Vision blurred — Feeling: Good · Chills, HeadacheFree text: Blurry visionMedDRA releases: 2024-11 · check-in free text available
-
2022-05-07
Survey response — days 1–6 daily, dose 4MedDRA: Vision blurred — Feeling: Fair · Muscle or body aches, Fatigue or tirednessFree text: Blurry visionMedDRA releases: 2024-11 · check-in free text available
-
2022-05-08
Survey response — days 1–6 daily, dose 4MedDRA: Vision blurred — Feeling: Good · Fatigue or tirednessFree text: Blurry visionMedDRA releases: 2024-11 · check-in free text available
-
2022-05-09
Survey response — days 1–6 daily, dose 4MedDRA: Vision blurred — Feeling: Fair · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Blurry visionMedDRA releases: 2024-11 · check-in free text available
-
2022-05-10
Survey response — days 1–6 daily, dose 4MedDRA: Vision blurred — Feeling: GoodFree text: Slight blurry visionMedDRA releases: 2024-11 · check-in free text available
-
2022-05-11
Survey response — day 7, dose 4MedDRA: Vision blurred — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Slight blurry visionMedDRA releases: 2024-11 · check-in free text available
- 2022-05-18
- 2022-05-25
- 2022-06-01
- 2022-06-09
-
2022-06-15
Survey response — day 42, dose 4MedDRA: Dry eye, Office visit, Vision blurred — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: I have had a continued and worsening problem with dry eye/blurry vision since receiving the Covid vaccinations. I don't know if this problem is related but I did not have it before. It is a profound difference but I am otherwise well. · Healthcare visit (other): OphthalmologistMedDRA releases: 2024-11 · check-in free text available
-
2022-06-15
Report sent to call center — day 42, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-06-16
Call successfulParticipant prefers to complete VAERS report online
- 2022-08-03
-
2022-10-03
Dose 5 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-06
Survey response — days 1–6 daily, dose 5MedDRA: No adverse event — Feeling: Fair · Site: Pain · Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesFree text:MedDRA releases: 2024-11 · check-in free text available
-
2022-10-07
Survey response — days 1–6 daily, dose 5MedDRA: Vision blurred — Feeling: Good · Muscle or body aches, Fatigue or tirednessFree text: Blurry visionMedDRA releases: 2024-11 · check-in free text available
- 2022-10-09
- 2022-10-10
-
2022-10-17
Survey response — day 14, dose 5MedDRA: Chills, Headache, Oropharyngeal pain, Pain, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Might be getting a head cold..headache/alt. Sore throat/chills/aches..did home test..neg. For Covid-19MedDRA releases: 2024-11 · check-in free text available
- 2022-10-24
-
2022-10-31
Survey response — day 28, dose 5MedDRA: Asthma — Feeling: Good · Be unable to do your normal daily activitiesFree text: Asthma episodeMedDRA releases: 2024-11 · check-in free text available
-
2022-11-07
Survey response — day 35, dose 5MedDRA: Asthma, Pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: body aches and asthmaMedDRA releases: 2024-11 · check-in free text available
- 2022-11-14
-
2023-01-02
Survey response — 3 months, dose 5MedDRA: Asthma, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-02
Report sent to call center — 3 months, dose 5Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-01-04
Call successfulNot applicable - Accidental Reporting
-
2023-04-05
Survey response — 6 months, dose 5MedDRA: Chemotherapy, Ovarian cancer stage IV — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11
-
2023-04-05
Report sent to call center — 6 months, dose 5Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2023-04-06
- 2023-04-11
-
2023-04-21
Callback requested for10:00AM ET
-
2023-04-21
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-16 | Pfizer-BioNTech | |
| 2 | 2021-03-17 | Pfizer-BioNTech | |
| 3 | 2021-10-08 | Pfizer-BioNTech | No |
| 4 | 2022-05-04 | Pfizer-BioNTech | No |
| 5 | 2022-10-03 | Pfizer-BioNTech | Flu |
Call center
6 call center cases
6 successful
VAERS report filed, before or during a call: 2
Free text
Release 5 — day 0, dose 2
Systemic reaction (other): Stiff jaw
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Stiff jaw and neck, swollen lymph node, all left side
Systemic reaction (other): No jaw stiffness, No swollen lymph nodes
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Sore throat and swollen lymph nodes
Systemic reaction (other): Swollen lymph nodes, sore throat
Release 9 — 3 months, dose 2
Symptoms: Eye irritations just recently re-diagnosed as Pink Eye and some fatigue.
Healthcare visit (other): Outpatient Eye Clinic
Release 9 — 6 months, dose 2
Symptoms: I am having ongoing problems with my eyes..requiring steroid drops and have had the worst case of poison Ivy Ive ever had requiring 2 courses of prednisone. ALL issues related to some kind of inflammation and NOT typical for me :/
Healthcare visit (other): Ophthalmology appointments
Release 11 — 12 months, dose 2
Symptoms: I have had ongoing problems with my eyes, requiring prescription eye drops..but otherwise I have been great.
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Blurry vision
Systemic reaction (other): Blurry vision
Systemic reaction (other): Blurry vision
Systemic reaction (other): Blurry vision
Systemic reaction (other): Slight blurry vision
Release 11 — day 7, dose 4
Systemic reaction (other): Slight blurry vision
Release 12 — day 42, dose 4
Symptoms: I have had a continued and worsening problem with dry eye/blurry vision since receiving the Covid vaccinations. I don't know if this problem is related but I did not have it before. It is a profound difference but I am otherwise well.
Healthcare visit (other): Ophthalmologist
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Blurry vision
Release 12 — day 14, dose 5
Symptoms: Might be getting a head cold..headache/alt. Sore throat/chills/aches..did home test..neg. For Covid-19
Release 12 — day 28, dose 5
Symptoms: Asthma episode
Release 12 — day 35, dose 5
Symptoms: body aches and asthma
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Chemotherapy | · | · | ✓ |
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Asthma | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Conjunctivitis | ✓ | ✓ | ✓ |
| SD | Dermatitis contact | · | · | ✓ |
| SD | Dry eye | · | · | ✓ |
| SD | Eye disorder | · | · | ✓ |
| SD | Eye irritation | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Ovarian cancer stage IV | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Vision blurred | · | · | ✓ |
| SRO | Joint stiffness | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Musculoskeletal stiffness | ✓ | ✓ | ✓ |
| SRO | No adverse event | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Vision blurred | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release